Results for aromatase inhibitors translation from English to Slovenian

inhibitors
blokkar

inhibitors.
odmerka ketokonazola.

inhibitors:
citalopram, escitalopram,

ace inhibitors
zaviralci ace

cyp2a6 inhibitors
inhibitorji cyp2a6

administration in combination with an aromatase inhibitor
odmerjanje v kombinaciji z zaviralcem aromataze

eau guidelines suggest the use of prophylactic breast radiation, tamoxifen or aromatase inhibitors to manage these symptoms, although they are not licensed in this use.
v smernicah eau je predlagano, da bi za urejanje teh simptomov uporabljali obsevanje prsi, tamoksifen ali zaviralce aromataze, čeprav slednji niso odobreni za uporabo v te namene.

the women had not received trastuzumab or an aromatase inhibitor before entering this study.
bolnice pred začetkom študije še niso prejemale trastuzumaba ali zaviralcev aromataze.

refer to the smpc for paclitaxel, docetaxel or aromatase inhibitor for information on dose reduction or delays.
za zmanjšanje odmerka ali odlog dajanja paklitaksela, docetaksela ali zaviralca aromataze glejte njihove povzetke glavnih značilnosti zdravila.

please refer to the full prescribing information of the co-administered aromatase inhibitor for dosing details.
za podrobnosti o odmerjanju sočasno uporabljenega zaviralca aromataze glejte celotno informacijo za njegovo predpisovanje.

no data are available on the efficacy of this combination relative to trastuzumab in combination with an aromatase inhibitor in this patient population.
podatkov o učinkovitosti te kombinacije v primerjavi s kombinacijo trastuzumaba in zaviralca aromataze pri tej populaciji bolnic ni.

in combination with an aromatase inhibitor for postmenopausal women with hormone receptor positive metastatic disease, not currently intended for chemotherapy.
v kombinaciji z zaviralcem aromataze pri postmenopavzalnih ženskah z metastatsko boleznijo, pozitivno glede hormonskih receptorjev, ki trenutno niso namenjene za kemoterapijo.

it is also used in combination with other anticancer medicines: with paclitaxel or docetaxel, or with an aromatase inhibitor;
uporablja se tudi v kombinaciji z drugimi zdravili proti raku: s paklitakselom ali docetakselom ali v kombinaciji z inhibitorjem aromataze;

in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive mbc, not previously treated with trastuzumab.
v kombinaciji z zaviralcem aromataze za zdravljenje bolnic v postmenopavzi z metastatsko obliko raka dojk s pozitivnimi hormonskimi receptorji, ki predhodno niso bile zdravljene s trastuzumabom.

refer to the summary of product characteristics (smpc) for paclitaxel, docetaxel or aromatase inhibitor for information on dose reduction or delays.
za zmanjšanje odmerka ali odlog dajanja paklitaksela, docetaksela ali zaviralca aromataze glejte njihove povzetke glavnih značilnosti zdravila.

the period of enrolment to the study (december 2003 – december 2006) preceded the adoption of trastuzumab in combination with an aromatase inhibitor.
obdobje vključevanja v študijo (od decembra 2003 do decembra 2006) je bilo še pred sprejetjem trastuzumaba v kombinaciji z zaviralcem aromataze.

the patients in the registration study were not previously treated with trastuzumab or an aromatase inhibitor (see sections 4.4. and 5.1).
bolnice v registracijski študiji predhodno niso bile zdravljene s trastuzumabom ali zaviralcem aromataze (glejte poglavji 4.4 in 5.1).

if you receive herceptin with any other medicine to treat cancer, such as paclitaxel, docetaxel, an aromatase inhibitor, carboplatin or cisplatin you should also read the patient information leaflets for these products.
Če prejemate zdravilo herceptin z drugimi zdravili za zdravljenje raka, kot so paklitaksel, docetaksel, zaviralec aromataze, karboplatin ali cisplatin, preberite tudi navodila za uporabo teh zdravil.

it is given together with a medicine called exemestane, a steroidal aromatase inhibitor, which is used for hormonal anticancer therapy. advanced tumours called neuroendocrine tumours that originate from the stomach, bowels, lung or pancreas.
jemlje se skupaj z zdravilom, imenovanim eksemestan, steroidni zaviralec aromataze, ki se uporablja za hormonsko zdravljenje raka. napredovalimi tumorji, ki se imenujejo nevroendokrini tumorji in izvirajo iz želodca, črevesja, pljuč ali trebušne slinavke.

inhibitor
encimski inhibitor